Intrinsic Value

The intrinsic value of Claritev Corp (CTEV) under the Base Case is 217.58 USD per share. Compared with the current market price of 23.5 USD, the stock appears Undervalued by 89% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CTEV Intrinsic Value
$217.58
Undervaluation 89%
Intrinsic Value
Price $23.5

CTEV is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor CTEV
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $174.07
Get notified when the price drops into your buy zone
Intrinsic Value $217.58
Margin of Safety 20% $174.07
Current Price $23.5
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CTEV

Fundamental Analysis

What Claritev Does

Health Care

Claritev Corp helps payers, employers, and other health plan sponsors lower and manage medical costs. The company sits in the middle of the U.S. healthcare billing system and checks medical claims against contracted rates, market pricing, and other payment rules before they are paid. It also offers tools that help customers understand prices, negotiate payments, and manage network access for providers.

Headquarters
United States of America US
Employees
3 000
IPO date
Feb 10, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Claritev Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CTEV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CTEV stock?

The intrinsic value for Claritev Corp (CTEV) under the Base Case is 217.58 USD.

Is CTEV stock undervalued or overvalued?

Compared with the current market price of 23.5 USD, the stock appears Undervalued by 89% .

Back to Top